Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Helen-Teresa Edwards"'
Autor:
Janet A. Dunn, Sophie Gasson, Sophie Nicholls, Jan Rose, Helen Teresa Edwards, Andrea Marshall, Natalie Hammonds, Beatrix Elsberger, Amit Goyal
Publikováno v:
Breast, Vol 68, Iss , Pp 241-242 (2023)
Externí odkaz:
https://doaj.org/article/6359ef9646734085bde90de382b811b6
Autor:
Amit Goyal, Sophie Nicholls, Andrea Marshall, Natalie Hammonds, Duncan Wheatley, Beatrix Elsberger, Janice Rose, Helen-Teresa Edwards, Roeum Butt, Abeer Shaaban, Shama Puri, Samreen Ahmed, Tara Homer, Luke Vale, Julie Bruce, Sophie J. Gasson, Helen Higgins, Janet A. Dunn
Publikováno v:
Cancer Research. 83:OT1-09
Background: For patients who are node positive at presentation and are found to have a complete nodal tumour response (ypN0) post-neoadjuvant chemotherapy (NACT), we do not yet know whether local axillary therapy can be modified based on the response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feecd0043f694b5f1f466879074deae0
https://doi.org/10.1158/1538-7445.sabcs22-ot1-09-02
https://doi.org/10.1158/1538-7445.sabcs22-ot1-09-02
Autor:
Amit Goyal, Sophie Cramp, Andrea Marshall, Duncan Wheatley, Natalie Hammonds, Shama Puri, Tara Homer, Luke Vale, Roeum Butt, Romaana Mir, Janice Rose, Helen Teresa Edwards, Samreen Ahmed, Abeer Shaaban, Beatrix Elsberger, Julie Bruce, Sophie Gasson, Valerie Speirs, Jacqui Shaw, Helen Higgins, Janet Dunn
Publikováno v:
Cancer Research. 82:OT1-04
Background: For patients who are node positive to start at presentation and are found to have a complete nodal tumour response (ypN0) post neoadjuvant chemotherapy (NACT), we do not yet know whether local axillary therapy can be modified based on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb69393a4e9da940b5b1efbe9f9b98d9
https://doi.org/10.1158/1538-7445.sabcs21-ot1-04-01
https://doi.org/10.1158/1538-7445.sabcs21-ot1-04-01
Autor:
Amit Goyal, Sophie Cramp, Andrea Marshall, Natalie Hammonds, Duncan Wheatley, Beatrix Elsberger, Shama Puri, Tara Homer, Luke Vale, Roeum Butt, Zohal Nabi, Janice Rose, Helen Teresa Edwards, Samreen Ahmed, Abeer Shaaban, Julie Bruce, Sophie Gasson, Helen Higgins, Janet Dunn
Publikováno v:
Journal of Clinical Oncology. 40:TPS615-TPS615
TPS615 Background: Neoadjuvant chemotherapy (NACT) results in eradication of cancer in the axillary nodes in 40-70% of patients. This raises questions about the benefit of further axillary treatment in patients with no evidence of residual nodal dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d18145d07421009770916ca75cb5227
https://doi.org/10.1200/jco.2022.40.16_suppl.tps615
https://doi.org/10.1200/jco.2022.40.16_suppl.tps615
Autor:
Julie Bruce, Sophie Gasson, Janice Rose, Shama Puri, Sophie Cramp, Natalie Hammonds, Amit Goyal, Helen Teresa Edwards, Janet A. Dunn, Valerie Speirs, Jacqui Shaw, Helen B Higgins, Romaana Mir, Duncan Wheatley, Abeer M Shaaban, Andrea Marshall, Luke Vale, Tara Homer, Beatrix Elsberger, Samreen Ahmed
Publikováno v:
Journal of Clinical Oncology. 39:TPS600-TPS600
TPS600 Background: Neoadjuvant chemotherapy (NACT) results in eradication of cancer in the axillary nodes in 40% to 70% of patients. This raises questions about the benefit of further axillary treatment in those patients with no evidence of residual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6088358fe90cb8ec5ad442bfc134a0a0
https://doi.org/10.1200/jco.2021.39.15_suppl.tps600
https://doi.org/10.1200/jco.2021.39.15_suppl.tps600
Autor:
Shama Puri, Duncan Wheatley, Helen Teresa Edwards, Abeer M Shaaban, Valerie Speirs, Luke Vale, Zohal Nabi, Amit Goyal, Andrea Marshall, Tara Homer, Jacqui Shaw, Helen B Higgins, Julie Bruce, Sophie Cramp, Samreen Ahmed, Romaana Mir, Janet A. Dunn, B. Elsberger, Janice Rose, Sophie Gasson
Publikováno v:
Cancer Research. 81:OT-04
Background: Neoadjuvant chemotherapy (NACT) results in eradication of cancer in the axillary lymph nodes in 40% to 70% of patients. This has raised questions about the benefit of further axillary treatment in these patients with no evidence of residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::138ecaf0288eec980c8f2b161734b470
https://doi.org/10.1158/1538-7445.sabcs20-ot-04-01
https://doi.org/10.1158/1538-7445.sabcs20-ot-04-01